NLRP3 E311K mutation in a large family with Muckle-Wells syndrome - description of a heterogeneous phenotype and response to treatment-Reference-Cited by-同舟云学术

NLRP3 E311K mutation in a large family with Muckle-Wells syndrome - description of a heterogeneous phenotype and response to treatment

Published:2011 Issue:6 Volume:13 Page:R196
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Kuemmerle-Deschner Jasmin B,Lohse Peter,Koetter Ina,Dannecker Guenther E,Reess Fabian,Ummenhofer Katharina,Koch Silvia,Tzaribachev Nikolay,Bialkowski Anja,Benseler Susanne M

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference21 articles.

1. Genetic Linkage of the Muckle-Wells Syndrome to Chromosome 1q44

2. Natural History and Outcome in Systemic AA Amyloidosis

3. Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever

4. Identifying Mutations in Autoinflammatory Diseases

5. INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: The altered rate of monocytic cell death in a patient of Muckle-Wells syndrome with atypical clinical course;Frontiers in Pediatrics;2023-02-16

2. Cardiovascular manifestations of monogenic periodic fever syndromes;Clinical Rheumatology;2023-01-09

3. A unique presentation of NLRP3-associated autoinflammatory disease: case report;BMC Rheumatology;2022-12-12

4. NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies;Frontiers in Immunology;2022-10-06

5. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist;Annals of the Rheumatic Diseases;2022-05-27